Abstract
—In the Board of Trustees Report entitled "Requirements or Incentives by Government for the Use of Long-Acting Contraceptives," published in the April 1,1992, issue ofTHE JOURNAL(1992;267:1818-1821), on page 1818 in the fourth paragraph, the third sentence should be two sentences and read as follows: "Nevertheless, because of the potential risks of supplemental hormonal therapy Norplant is contraindicated for patients with thrombotic disease, acute liver dysfunction, or breast cancer [not "diabetes, hypertension, cardiovascular disease, thrombotic disease, acute liver dysfunction, or breast cancer"]. Patients with diabetes, hypertension, or cardiovascular disease should be monitored for adverse effects."
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
